Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

The Clinical Cancer Letter, April 2011. Vol. 34, No. 4

publication date: May 4, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
  • Study finds that IMRT usage and cost related to geography and Medicare reimbursement policy
  • Aflibercept improves overall survival in second-line colorectal cancer setting
  • FDA News: Centocor withdraws NDA application for Yondelis
  • NCI approved trials for the month of April



To access this members-only content, please log in.

If you're not a subscriber why not join today?

If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.